Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors
GenVivo, Inc.
GenVivo, Inc.
National Institutes of Health Clinical Center (CC)
The Methodist Hospital Research Institute
City of Hope Medical Center
National Taiwan University Hospital
Rznomics, Inc.
Sun Yat-sen University
Viracta Therapeutics, Inc.